Resources | NITAG RESOURCE CENTER

2026 ∙ JCVI

A guide to immunisation for babies up to 13 months of age: for children born on or after 1 January 2025

2026 ∙ NACI

Updated Guidance for Use of Rabies Vaccine for Pre-Exposure Prophylaxis (PrEP)

2026 ∙ Burger, E., Jean-François Laprise, Jennifer C. Spencer, Stephen Sy, Mary Caroline Regan, Melanie Drolet, Éléonore Chamberland, Marc Brisson, Jane Kim

Single-dose HPV vaccination in the United States - a multi-modeling analysis

2026 ∙ STIKO

Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2026

2026

Recommendations on pneumococcal vaccination to at-risk groups

2026 ∙ STIKO

Update of the STIKO recommendation on vaccination against pneumococcal disease for children and adolescents with risk factors aged ≥ 2 to 17 years

2025 ∙ Ndzouboukou, J. L. B. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.

A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy Adults

2025 ∙ Banga Ndzouboukou, J. L. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.

A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults

2025 ∙ Vittrup, D. M. Charabi, S. Jensen, A. Stensballe, L. G.

A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age

2025 ∙ Kitano, T. Salmon, D. A. Dudley, M. Z. Saldanha, I. J. Thompson, D. A. Engineer, L.

A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions